Feb 6 (Reuters) - U.S. drugstore chain Walgreens Boots Alliance WBA.O said on Thursday it has sold more shares in drug distributor Cencora COR.N for proceeds of about $300 million.
The company said that it now owns a 6% stake in Cencora, trimming it down from 10% it previously held. It sold Cencora shares worth $1.1 billion in August.
Walgreens has sold about $265 million worth of shares and Cencora has agreed to repurchase about $50 million worth of shares, the company said in a statement.
Proceeds from the share sale will be used primarily for debt pay down and general corporate purposes, as Walgreens continues to build out a more capital-efficient health services strategy rooted in its retail pharmacy footprint.
The pharmacy chain reiterated that the sale has no impact to the long-term partnership between the two companies.
(Reporting by Pretish M J in Bengaluru; Editing by Rashmi Aich)
((PretishMJ@thomsonreuters.com; +91 8056974974;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。